We show here for the first time that inhibition of AKT pathway in Dox-treated STS and GIST reduces Rad51 levels and inhibits recruitment of Rad51 recombinase to sites of DNA DSBs after Dox treatment, thereby attenuating the homology-mediated repair mechanisms. The gene discussed is RAD51; the disease is gastrointestinal stromal tumor.